David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.55% |
| 2 | Consumer Discretionary | 8.97% |
| 3 | Financials | 8.5% |
| 4 | Healthcare | 8.44% |
| 5 | Industrials | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
PUT
Cameco
CCJ
$45.7B
| $34M | 0.02% |
312,900
+150,800
| +93% | +$17.3M |
|
802
CALL
Amgen
AMGN
$240B
| $34M | 0.02% |
96,500
-24,400
| -20% | -$8.7M |
|
803
Royal Caribbean
RCL
$77.8B
| $33.9M | 0.02% |
123,351
-224,986
| -65% | -$67M |
|
804
Moderna
MRNA
$60.6B
| $33.9M | 0.02% |
666,532
-4,516,227
| -87% | -$211M |
|
805
PUT
SLB Ltd
SLB
$79.7B
| $33.7M | 0.02% |
656,100
-779,500
| -54% | -$37.8M |
|
806
The Greenbrier Companies
GBX
$1.43B
| $33.7M | 0.02% |
639,913
+88,151
| +16% | +$4.66M |
|
|
VISN
807
Vistance Networks Inc
VISN
$2.51B
| $33.5M | 0.02% |
1,842,595
-1,692,146
| -48% | -$30.9M |
|
808
GE HealthCare
GEHC
$33.1B
| $33.5M | 0.02% |
470,374
-837,294
| -64% | -$66M |
|
809
PUT
Rocket Lab Corp
RKLB
$42.7B
| $33.4M | 0.02% |
520,600
+268,200
| +106% | +$20.2M |
|
810
Charles River Laboratories
CRL
$14.3B
| $33.4M | 0.02% |
193,483
-237,645
| -55% | -$44.1M |
|
811
CALL
Blackrock
BLK
$181B
| $33.4M | 0.02% |
34,700
+16,100
| +87% | +$16.9M |
|
812
PUT
Intuitive Surgical
ISRG
$132B
| $33.3M | 0.02% |
+72,200
| New | +$36.5M |
|
813
Plexus
PLXS
$6.38B
| $33.2M | 0.02% |
163,947
-41,633
| -20% | -$7.91M |
|
814
Commerce Bancshares
CBSH
$8.36B
| $33.2M | 0.02% |
674,301
+34,027
| +5% | +$1.77M |
|
815
PUT
Manulife Financial
MFC
$70.8B
| $33.1M | 0.02% |
962,500
-1,287,600
| -57% | -$46.3M |
|
816
Dick's Sporting Goods
DKS
$12.1B
| $33.1M | 0.02% |
167,033
-161,796
| -49% | -$32.8M |
|
|
TXNM
817
TXNM Energy Inc
TXNM
$5.9B
| $33.1M | 0.02% |
565,921
-856,455
| -60% | -$50.5M |
|
818
Manhattan Associates
MANH
$12.4B
| $33.1M | 0.02% |
248,485
-25,566
| -9% | -$3.83M |
|
819
PUT
Datadog
DDOG
$80.9B
| $33.1M | 0.02% |
280,000
-765,100
| -73% | -$94.5M |
|
820
Navitas Semiconductor
NVTS
$3.26B
| $33M | 0.02% |
3,767,604
+3,203,751
| +568% | +$29.5M |
|
821
Interactive Brokers
IBKR
$42.7B
| $33M | 0.02% |
491,508
+466,791
| +1,889% | +$33.3M |
|
822
Valaris
VAL
$5.89B
| $33M | 0.02% |
336,221
+287,160
| +585% | +$22.4M |
|
823
Liquidia Corp
LQDA
$6.46B
| $32.9M | 0.02% |
873,065
-794,317
| -48% | -$29.5M |
|
824
PUT
Intuit
INTU
$98.7B
| $32.9M | 0.02% |
76,100
+25,100
| +49% | +$12M |
|
825
PUT
LyondellBasell Industries
LYB
$20.4B
| $32.9M | 0.02% |
408,100
-25,000
| -6% | -$1.48M |
|
Similar funds
David Shaw's Q1 2026 Portfolio in Review
As of Q1 2026, David Shaw held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15.1B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, David Shaw opened a new position in Venture Global Inc worth $211M.
- David Shaw's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- David Shaw added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- David Shaw's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- David Shaw's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- David Shaw opened 685 new positions and closed 756 in Q1 2026.
- David Shaw's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.